GATA factors participate in tissue-specific immune responses in Drosophila larvae

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 43, 2006, Pages 15957-15962

  Senger, Kate ^a   Harris, Kristina ^a   Levine, Mike ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

dGATAe; Innate immunity; Melanin; Midgut; Toll pathway

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATAC; TRANSCRIPTION FACTOR GATAD; TRANSCRIPTION FACTOR GATAE; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BODY FAT; CONTROLLED STUDY; DIPTERICIN GENE; DROSOPHILA; GENE; GENE ACTIVATION; GENE CONTROL; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; INTESTINE; LARVA; METCHNIKOWIN GENE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TRACHEA; TRANSCRIPTION REGULATION;

ANIMALS; DROSOPHILA MELANOGASTER; GATA TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LARVA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; PHENOTYPE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 33750492939     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0607608103     Document Type: Article

References (27)

1. Brennan CA, Anderson KV (2004) Annu Rev Immunol 22:457-483.
2. Leclerc V, Reichhart JM (2004) Immunol Rev 198:59-71.
3. Ferrandon D, Jung AC, Criqui M, Lemaitre B, Uttenweiler-Joseph S, Michaut L, Reichhart J, Hoffmann JA (1998) EMBO J 17:1217-1227.
4. Onfelt TT, Roos E, Engstrom Y (2001) EMBO Rep 2:239-243.
5. Tzou P, Ohresser S, Ferrandon D, Capovilla M, Reichhart JM, Lemaitre B, Hoffmann JA, Imler JL (2000) Immunity 13:737-748.
6. Dushay MS, Asling B, Hultmark D (1996) Proc Natl Acad Sci USA 17:10343-10347.
7. Ip TY, Reach M, Engstrom Y, Kadalayil L, Cai H, Gonzalez-Crespo S, Tatei K, Levine M (1993) Cell 19:753-763.
8. Lemaitre B, Meister M, Govind S, Georgel P, Steward R, Reichhart JM, Hoffmann JA (1995) EMBO J 14:536-545.
9. Petersen UM, Kadalayil L, Rehorn KP, Hoshizaki DK, Reuter R, Engstrom Y (1999) EMBO J 18:4013-4022.
10. Senger K, Armstrong GW, Rowell WJ, Kwan JM, Markstein M, Levine M (2004) Mol Cell 13:19-32.
11. Ko LJ, Engel JD (1993) Mol Cell Biol 13:4011-4022.
12. Merika M, Orkin SH (1993) Mol Cell Biol 13:3999-4010.
13. Patient RK, McGhee JD (2002) Curr Opin Genet Dev 12:416-422.
14. Okumura T, Matsumoto A, Tanimura T, Murakami R (2005) Dev Biol 278:576-586.
15. Murakami R, Okumura T, Uchiyama H (2005) Dev Growth Differ 47:581-589.
16. Manseau L, Baradaran A, Brower D, Budhu A, Elefant F, Phan H, Philip AV, Yang M, Glover D, Kaiser K, et al. (1997) Dev Dyn 209:310-322.
17. De Gregorio E, Spellman PT, Tzou P, Rubin GM, Lemaitre B (2002) EMBO J 17:1217-1227.
18. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Nucleic Acids Res 31:e15.
19. Werner T, Liu G, Rang D, Ekengren S, Steiner H, Hultmark D (2000)Proc Natl Acad Sci USA 97:13772-13777.
20. Bell JK, Mullen GE, Leifer CA, Mazzoni A, Davies DR, Segal DM (2003) Trends Immunol 24:528-533.
21. Inohara N, Nunez G (2002) Trends Biochem Sci 27:219-221.
22. Miyake K (2004) Semin Immunol 16:11-16.
23. Honey K, Rudensky AY (2003) Nat Rev Immunol 3:472-482.
24. Sam S, Leise W, Hoshizaki DK (1996) Mech Dev 60:197-205.
25. Levy S, Shoham T (2005) Nat Rev Immunol 5:136-148.
26. Brand AH, Perrimon N (1993) Development (Cambridge, UK) 118:401-415.
27. Jiang J, Kosman D, Ip YT, Levine M (1991) Genes Dev 5:1881-1891.